610 related articles for article (PubMed ID: 31888723)
1. Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).
Bayer O; Adrion C; Al Tawil A; Mansmann U; Strupp M;
Trials; 2019 Dec; 20(1):813. PubMed ID: 31888723
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for prophylaxis of vestibular migraine.
Webster K; Dor A; Galbraith K; Kassem LH; Harrington-Benton N; Judd O; Kaski D; Maarsingh O; MacKeith S; Ray J; Van Vugt V; Burton M
Cochrane Database Syst Rev; 2023 Apr; 2023(4):CD015187. PubMed ID: 37073858
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).
Adrion C; Fischer CS; Wagner J; Gürkov R; Mansmann U; Strupp M;
BMJ; 2016 Jan; 352():h6816. PubMed ID: 26797774
[TBL] [Abstract][Full Text] [Related]
4. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
7. The probiotic
Qi X; Fan G; Jia H
Benef Microbes; 2020 Sep; 11(5):469-476. PubMed ID: 32865025
[TBL] [Abstract][Full Text] [Related]
8. Vestibular migraine.
Strupp M; Versino M; Brandt T
Handb Clin Neurol; 2010; 97():755-71. PubMed ID: 20816468
[TBL] [Abstract][Full Text] [Related]
9. Preventing Episodic Migraine With Caloric Vestibular Stimulation: A Randomized Controlled Trial.
Wilkinson D; Ade KK; Rogers LL; Attix DK; Kuchibhatla M; Slade MD; Smith LL; Poynter KP; Laskowitz DT; Freeman MC; Hoffer ME; Saper JR; Scott DL; Sakel M; Calhoun AH; Black RD
Headache; 2017 Jul; 57(7):1065-1087. PubMed ID: 28656612
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
Stauffer VL; Dodick DW; Zhang Q; Carter JN; Ailani J; Conley RR
JAMA Neurol; 2018 Sep; 75(9):1080-1088. PubMed ID: 29813147
[TBL] [Abstract][Full Text] [Related]
11. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.
Ferrari MD; Diener HC; Ning X; Galic M; Cohen JM; Yang R; Mueller M; Ahn AH; Schwartz YC; Grozinski-Wolff M; Janka L; Ashina M
Lancet; 2019 Sep; 394(10203):1030-1040. PubMed ID: 31427046
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
13. Vestibular Migraine: How to Sort it Out and What to Do About it.
Beh SC
J Neuroophthalmol; 2019 Jun; 39(2):208-219. PubMed ID: 31094996
[TBL] [Abstract][Full Text] [Related]
14. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial.
Sun H; Dodick DW; Silberstein S; Goadsby PJ; Reuter U; Ashina M; Saper J; Cady R; Chon Y; Dietrich J; Lenz R
Lancet Neurol; 2016 Apr; 15(4):382-90. PubMed ID: 26879279
[TBL] [Abstract][Full Text] [Related]
16. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability.
Sørensen PS; Larsen BH; Rasmussen MJ; Kinge E; Iversen H; Alslev T; Nøhr P; Pedersen KK; Schrøder P; Lademann A
Headache; 1991 Nov; 31(10):650-7. PubMed ID: 1769820
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
18. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial.
Ashina M; Lanteri-Minet M; Pozo-Rosich P; Ettrup A; Christoffersen CL; Josiassen MK; Phul R; Sperling B
Lancet Neurol; 2022 Jul; 21(7):597-607. PubMed ID: 35716692
[TBL] [Abstract][Full Text] [Related]
20. Classic migraine: effective prophylaxis with metoprolol.
Kangasniemi P; Andersen AR; Andersson PG; Gilhus NE; Hedman C; Hultgren M; Vilming S; Olesen J
Cephalalgia; 1987 Dec; 7(4):231-8. PubMed ID: 3322569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
